Hadasit Bio-Holdings

Press Releases

Results of the General and Special Meeting dated October 25, 2015

Oct. 25, 2015

Results of the General and Special Meeting dated October 25, 2015

HBL - Hadasit Bio-Holdings Ltd. (the “Company”)

 

 

1.    Approval of granting stock options not listed for trade of the Company to the CEO of the Company, Ms. Tamar Kfir

Resolved to approve granting of 253,100 unlisted stock options for trade of the Company to Ms. Tamar Kfir under the terms set forth in Section 3.1of the invitation to the meeting, with a majority of 1,152,302 shares from 1,194,302 shares participating in the vote, and which do not have a personal interest, i.e. 97.32% of the participating shares, which do not have a personal interest, and a majority of 99.68% of the total shares participating.

 

2.    Approval of changing the terms of the stock options not listed for trade of the Company granted to the CEO of the Company, Ms. Tamar Kfir

Resolved to approve a change in the terms of the stock options granted to Ms. Tamar Kfir in accordance with the terms set forth in Section 3.2of the invitation to the meeting, with a majority of 983,424 shares from 1,194,302 shares participating in the vote, and which do not have a personal interest, i.e. 82.34% of the participating shares, which do not have a personal interest, and a majority of 97.91% of the total shares participating.

3.    Approval of granting stock options not listed for trade of the Company to the Chairman of the Company’s Board of Directors, Mr. Yigal Erlich

Resolved to approve granting of 72,950 unlisted stock options for trade of the Company to Mr. Yigal Erlich under the terms set forth in Section 3.3of the invitation to the meeting, with a majority of 1,152,302 shares from 1,194,302 shares participating in the vote, and which do not have a personal interest, i.e. 82.53% of the participating shares, which do not have a personal interest, and a majority of 97.93% of the total shares participating.

4.    Approval of changing the terms of the unlisted stock options for trade of the Company granted to the Chairman of the Board of Directors of the Company, Mr. Yigal Erlich

Resolved to approve a change in the terms of the stock options granted to Mr. Yigal Erlich under the terms set forth in Section 3.4of the invitation to the meeting, with a majority of 970,922 shares from 1,194,302 shares participating in the vote, and which do not have a personal interest, i.e. 82.15% of the participating shares, which do not have a personal interest, and a majority of 97.90% of the total shares participating.

5.    Approval of granting stock options not listed for trade of Enlivex Therapeutics Ltd. (hereinafter: “Enlivex”) to the CEO of the Company, Ms. Tamar Kfir

Resolved to approve granting of 274,679 unlisted stock options for trade of Enlivex to Ms. Tamar Kfir, for her service as director of Enlivex, with a majority of 972,881 shares from 1,181,800 shares participating in the vote, and which do not have a personal interest, i.e. 82.32% of the participating shares, which do not have a personal interest, and a majority of 97.92% of the total shares participating.

6.    Approval of granting unlisted stock options for trade of Enlivex Therapeutics Ltd. (hereinafter: " Enlivex") to the Chairman of the Board of Directors, Mr. Yigal Erlich

Resolved to approve granting of 274,679 unlisted stock options for trade of Enlivex to Mr. Yigal Erlich, for his service as director of Enlivex, with a majority of 972,881 shares from 1,181,800 shares participating in the vote, and which do not have a personal interest, i.e. 82.32% of the participating shares, which do not have a personal interest, and a majority of 97.92% of the total shares participating.

7.    Approval of granting unlisted stock options for trade of KAHR Medical (2005) Ltd. (hereinafter: “KAHR”) to the CEO of the Company, Ms. Tamar Kfir

Resolved to approve granting of 9,886 unlisted stock options for trade of KAHR to Ms. Tamar Kfir, for her service as director of KAHR, with a majority of 972,881 shares from 1,181,800 shares participating in the vote, and which do not have a personal interest, i.e. 82.36% of the participating shares, which do not have a personal interest, and a majority of 97.92% of the total shares participating.

8.    Approval of the appointment of Mr. Baruch Halpert for the role of director of the Company

Resolved to approve the appointment of Mr. Baruch Halpert to the role of director of the Company, with a majority of 92.92% of the total shares participating in the vote.

9.    Approval of the appointment of Adv. Oren Levy for the role of director of the Company

Resolved to approve the appointment of Adv. Oren Levy to the role of director of the Company, with a majority of 92.92% of the total shares participating in the vote.

 
 

Press Releases Archive